| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/11/2011 | CN101444560B Chinese drugs for intractable tinea treatment |
| 05/11/2011 | CN101433666B Anti-aging Chinese herbal medicinal composition, preparation method and use thereof |
| 05/11/2011 | CN101361910B Medicine for mainly treating sunlight, neurodermatitis accompanied with health preservation and beautification |
| 05/11/2011 | CN101361876B Wound-healing tissue-promoting powder and preparation method thereof |
| 05/11/2011 | CN101332274B Compound grape-seed cream and preparation method thereof |
| 05/11/2011 | CN101306027B Extracting method of medical mangrove acanthus total flavonoids |
| 05/11/2011 | CN101280258B Cosmetic nutritious health care yellow wine and preparation thereof |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/11/2011 | CN101234174B Liquid medicine for treating corn and onychomycosis |
| 05/11/2011 | CN101204456B Marinating medicine for hands and feet psoriasis |
| 05/11/2011 | CN101190228B Compound triamcinolone acetonide acetate solution production technology |
| 05/11/2011 | CN101167778B Semen vaccariae extraction for inhibiting angiogenesis and preparation and application thereof |
| 05/11/2011 | CN101129565B Medicament for treating beriberi, sweaty feet and foot odor |
| 05/11/2011 | CN101085283B Vein relaxing externally used lotion for dermatosis |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939639 Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology and physiology |
| 05/10/2011 | US7939540 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2-methylaminoquinazoline derivatives |
| 05/10/2011 | US7939504 Method of treating skin ulcers with vectors encoding hepatocyte growth factor |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | US7939082 Papilloma virus vaccine |
| 05/10/2011 | US7938641 Extrusion die |
| 05/10/2011 | CA2622805C Compressed tablets comprising valsartan |
| 05/10/2011 | CA2519063C Immunomodulating heterocyclic compounds |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2417806C New immunoeffector compounds |
| 05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
| 05/05/2011 | WO2011053571A1 Phytoestrogenic formulations for alleviation or prevention of hair loss |
| 05/05/2011 | WO2011053487A1 Methods of treating or preventing acute erythema |
| 05/05/2011 | WO2011053007A2 Composition for suppressing pore shrinkage or sebum secretion which comprises potentilla chinensis extract |
| 05/05/2011 | WO2011052830A1 Raspberry extract for enhancing skin immunity, combined pressure extraction method and extract therefrom |
| 05/05/2011 | WO2011052668A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | WO2011051813A1 Compositions and methods for treating dermatological conditions |
| 05/05/2011 | WO2011050948A1 Tape, in particular adhesive tape, for the treatment of skin disorders comprising a film, in particular dissolvable film, containing at least one enzyme |
| 05/05/2011 | WO2011050947A2 Tape, in particular, adhesive tape, for the treatment of skin disorders comprising at least one hyperkeratosis inhibitor and/or at least one keratinolytic agent |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | US20110105996 Methods for scar prevention |
| 05/05/2011 | US20110105748 Novel beta-phenyl-alpha-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 05/05/2011 | US20110105624 Endipalene formulations in the treatment of psoriasis |
| 05/05/2011 | US20110105611 Use of maslinic acid for the treatment of pathologies and their symptoms through the inhibition of cox-2 |
| 05/05/2011 | US20110105607 Lipophilic diesters of chelating agent for inhibition of enzyme activity |
| 05/05/2011 | US20110105606 Compositions and methods affecting the signaling pathways of LRP receptors |
| 05/05/2011 | US20110105584 Rtp80il sirna compounds and methods of use thereof |
| 05/05/2011 | US20110105573 Benzimidazole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 05/05/2011 | US20110105572 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105563 Il-8 receptor antagonists |
| 05/05/2011 | US20110105543 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105538 Drug response markers |
| 05/05/2011 | US20110105530 Organic compounds |
| 05/05/2011 | US20110105527 Pyrazines as delta opioid receptor modulators |
| 05/05/2011 | US20110105523 Bifeprunox derivatives |
| 05/05/2011 | US20110105509 Indole based receptor crth2 antagonists |
| 05/05/2011 | US20110105505 Thiazolyl piperidine derivatives |
| 05/05/2011 | US20110105499 Pyrazolo-Pyrazinone Compounds and Methods of Use Thereof |
| 05/05/2011 | US20110105498 Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof |
| 05/05/2011 | US20110105478 Novel 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives useful as modulator of nicotinic acetylcholine receptors |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105440 HEXAHYDROCYCLOPENTYL[f]INDAZOLE SULFONAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105427 Deazapurines and uses thereof |
| 05/05/2011 | US20110105424 Glucopyranoside compound |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105382 Calmodulin-binding peptides that reduce cell proliferation in cancer and smooth muscle proliferation diseases |
| 05/05/2011 | US20110104280 Wound treatment systems, devices, and methods using biocompatible synthetic hydrogel compositions |
| 05/05/2011 | US20110104279 Healing powder and method of use thereof |
| 05/05/2011 | US20110104274 Novel composition and uses thereof, in particular cosmetic uses, for treating skin dehydration |
| 05/05/2011 | US20110104254 Medicament for treatment of tumors wherein hedgehog/smoothened signaling is employed for inhibition of apoptosis of the tumor cells |
| 05/05/2011 | US20110104246 Method of wound treatment using liquid gallium nitrate |
| 05/05/2011 | US20110104240 Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections |
| 05/05/2011 | US20110104232 Sustained Release Systems of Ascorbic Acid Phosphate |
| 05/05/2011 | US20110104225 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104185 Antibody fragment-polymer conjugates and uses of same |
| 05/05/2011 | US20110104176 Antibody specifically binding to c-met and use thereof |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104144 Methods for treating cutaneous lupus using aminoisoindoline compounds |
| 05/05/2011 | US20110104139 ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME |
| 05/05/2011 | US20110104127 mRNA-TRANSFECTION OF ADULT PROGENITOR CELLS FOR SPECIFIC TISSUE REGENERATION |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | DE10340417C5 Kosmetische oder dermatologische Zubereitung mit Phytosterolen in Form einer W/O-Emulsion Cosmetic or dermatological preparation with phytosterols in the form of a W / O emulsion |
| 05/05/2011 | CA2779400A1 Compositions and methods for treating dermatological conditions |
| 05/05/2011 | CA2779063A1 Methods of treating or preventing acute erythema |
| 05/05/2011 | CA2779025A1 Therapeutic uses of oligomeric and polymeric monoterpenes |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316919A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316918A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 05/04/2011 | EP2316845A1 Specific binding agents of human angiopoietin-2 |